SELECT MED HLDGS CORP's ticker is SEM and the CUSIP is 81619Q105. A total of 254 filers reported holding SELECT MED HLDGS CORP in Q2 2024. The put-call ratio across all filers is 0.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $3,858,037 | -4.2% | 110,041 | -17.6% | 0.88% | -3.2% |
Q1 2024 | $4,026,261 | +6.9% | 133,541 | -16.7% | 0.91% | -4.4% |
Q4 2023 | $3,768,014 | -13.4% | 160,341 | -6.8% | 0.95% | -7.3% |
Q3 2023 | $4,349,397 | -32.8% | 172,117 | -15.3% | 1.02% | -34.3% |
Q2 2023 | $6,471,307 | +96.2% | 203,117 | +59.2% | 1.56% | +90.7% |
Q1 2023 | $3,298,537 | +5.8% | 127,603 | +1.6% | 0.82% | +3.7% |
Q4 2022 | $3,118,723 | +41.6% | 125,603 | +26.1% | 0.79% | +27.6% |
Q3 2022 | $2,202,000 | -12.1% | 99,619 | -6.1% | 0.62% | -11.9% |
Q2 2022 | $2,506,000 | -31.4% | 106,084 | -30.3% | 0.70% | -22.6% |
Q1 2022 | $3,651,000 | -20.1% | 152,184 | -2.1% | 0.90% | -24.7% |
Q4 2021 | $4,571,000 | -14.6% | 155,484 | +5.0% | 1.20% | -13.2% |
Q3 2021 | $5,354,000 | +49.5% | 148,032 | +74.7% | 1.38% | +51.5% |
Q2 2021 | $3,581,000 | +26.0% | 84,732 | +1.7% | 0.91% | +18.9% |
Q1 2021 | $2,842,000 | +58.9% | 83,332 | +28.9% | 0.77% | +30.8% |
Q4 2020 | $1,788,000 | – | 64,632 | – | 0.59% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Hillcrest Asset Management LLC | 455,999 | $13,406,000 | 2.04% |
Smith, Graham & Co., Investment Advisors, LP | 445,634 | $13,102,000 | 1.30% |
DENALI ADVISORS LLC | 118,200 | $3,475,000 | 1.30% |
Huber Capital Management LLC | 155,484 | $4,571,000 | 1.20% |
Sivik Global Healthcare LLC | 90,000 | $2,646,000 | 1.13% |
Hood River Capital Management LLC | 1,163,403 | $34,204,000 | 1.02% |
Phocas Financial Corp. | 234,059 | $6,881,000 | 0.88% |
BOULDER HILL CAPITAL MANAGEMENT LP | 18,600 | $547,000 | 0.53% |
Orbimed Advisors | 1,233,600 | $36,268,000 | 0.47% |
FULLER & THALER ASSET MANAGEMENT, INC. | 2,385,402 | $70,131,000 | 0.41% |